Description:

E2805 Concomitant Medication Form Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0B593E1B-ACB3-37BB-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0B593E1B-ACB3-37BB-E044-0003BA3F9857

Keywords:
Versions (8) ▾
  1. 9/19/12
  2. 11/26/14
  3. 11/26/14
  4. 11/26/14
  5. 1/8/15
  6. 1/9/15
  7. 1/9/15
  8. 7/14/17
Uploaded on:

July 14, 2017

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Kidney Cancer NCT00326898 Treatment - E2805 Concomitant Medication Form - 2444090v1.0

No Instruction available.

  1. StudyEvent: E2805 Concomitant Medication Form
    1. No Instruction available.
Administrative documentation
Concomitant medication
Units (*)
Frequency (**)
Route (***)
Is this medication continuing?
On Treatment Report Period (since start of treatment If treatment was delayed, choose the intended time period without delays.)
Were concomitant medications used during this reporting period? (reportable)
Comments

Similar models